title: [Betablockers and hypoglycemia].
authors.forename: A
authors.initials: A
authors.lastname: Grimaldi
authors.forename: P
authors.initials: P
authors.lastname: Bennet
authors.forename: B
authors.initials: B
authors.lastname: Delas
authors.forename: C
authors.initials: C
authors.lastname: Chapelon
authors.forename: F
authors.initials: F
authors.lastname: Lebargy
authors.forename: J
authors.initials: J
authors.lastname: Sobel
authors.forename: F
authors.initials: F
authors.lastname: Bosquet
mesh_terms: D000070:Acebutolol / Q000009:adverse effects; D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D000328:Adult; D001786:Blood Glucose / Q000378:metabolism; D005260:Female; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced*; D007328:Insulin; D061389:Insulin, Regular, Pork; D007700:Kinetics; D008297:Male; D010869:Pindolol / Q000009:adverse effects
chemical_list: D000319:Adrenergic beta-Antagonists; D001786:Blood Glucose; D007328:Insulin; D061389:Insulin, Regular, Pork; D000070:Acebutolol; C000006:insulin, neutral; D010869:Pindolol
vernacular_title: Bêta-bloquants et hypoglycémie.